Peter Groitl

2.0k total citations
40 papers, 1.6k citations indexed

About

Peter Groitl is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Peter Groitl has authored 40 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 32 papers in Genetics and 10 papers in Immunology. Recurrent topics in Peter Groitl's work include Virus-based gene therapy research (31 papers), interferon and immune responses (10 papers) and RNA Interference and Gene Delivery (8 papers). Peter Groitl is often cited by papers focused on Virus-based gene therapy research (31 papers), interferon and immune responses (10 papers) and RNA Interference and Gene Delivery (8 papers). Peter Groitl collaborates with scholars based in Germany, Canada and United Kingdom. Peter Groitl's co-authors include Thomas Dobner, Sabrina Schreiner, Paola Blanchette, Peter Wimmer, Martin Lipp, Philip E. Branton, Berthold Henglein, Roger D. Everett, Frédéric Dallaire and P. Hartl and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

Peter Groitl

40 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Groitl Germany 24 1.1k 949 434 370 269 40 1.6k
Steven J. Werden United States 19 813 0.7× 478 0.5× 345 0.8× 574 1.6× 326 1.2× 23 1.6k
Frédérique Quignon France 19 2.1k 1.8× 448 0.5× 818 1.9× 346 0.9× 285 1.1× 28 2.6k
Andrew M. Lewis United States 27 1.2k 1.0× 1.2k 1.3× 262 0.6× 923 2.5× 117 0.4× 77 2.0k
Denise R. Shaw United States 21 858 0.7× 392 0.4× 493 1.1× 298 0.8× 108 0.4× 34 1.4k
Polly R. Etkind United States 19 548 0.5× 295 0.3× 245 0.6× 221 0.6× 496 1.8× 30 1.2k
Chiara Bovolenta Italy 22 660 0.6× 440 0.5× 839 1.9× 580 1.6× 152 0.6× 45 1.6k
Marilyn R. Lander United States 15 658 0.6× 668 0.7× 521 1.2× 190 0.5× 210 0.8× 18 1.4k
Bhavin S. Parekh United States 12 1.3k 1.2× 227 0.2× 1.1k 2.6× 513 1.4× 245 0.9× 16 2.4k
Lex M. Cowsert United States 16 759 0.7× 309 0.3× 201 0.5× 194 0.5× 374 1.4× 29 1.3k
M Kuppuswamy United States 18 766 0.7× 525 0.6× 149 0.3× 232 0.6× 138 0.5× 27 1.5k

Countries citing papers authored by Peter Groitl

Since Specialization
Citations

This map shows the geographic impact of Peter Groitl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Groitl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Groitl more than expected).

Fields of papers citing papers by Peter Groitl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Groitl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Groitl. The network helps show where Peter Groitl may publish in the future.

Co-authorship network of co-authors of Peter Groitl

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Groitl. A scholar is included among the top collaborators of Peter Groitl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Groitl. Peter Groitl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Groitl, Peter, Maryam Karimi, Paola Blanchette, et al.. (2024). The human adenovirus PI3K-Akt activator E4orf1 is targeted by the tumor suppressor p53. Journal of Virology. 98(4). e0170123–e0170123. 2 indexed citations
2.
Paulus, Christina, Hans Stubbe, Maryam Karimi, et al.. (2020). Viral DNA Binding Protein SUMOylation Promotes PML Nuclear Body Localization Next to Viral Replication Centers. mBio. 11(2). 24 indexed citations
3.
Amero, Carlos, Nina Pastor, Ángel Santiago, et al.. (2019). The human adenovirus type 5 E1B 55kDa protein interacts with RNA promoting timely DNA replication and viral late mRNA metabolism. PLoS ONE. 14(4). e0214882–e0214882. 4 indexed citations
4.
Groitl, Peter, et al.. (2017). Human Adenovirus Core Protein V Is Targeted by the Host SUMOylation Machinery To Limit Essential Viral Functions. Journal of Virology. 92(4). 12 indexed citations
5.
Wimmer, Peter, Paola Blanchette, Peter Groitl, et al.. (2015). PML isoforms IV and V contribute to adenovirus-mediated oncogenic transformation by functionally inhibiting the tumor-suppressor p53. Oncogene. 35(1). 69–82. 18 indexed citations
6.
Никитенко, Н. А., Thomas Speiseder, Peter Groitl, et al.. (2015). Targeting species D adenoviruses replication to counteract the epidemic keratoconjunctivitis. Biochimie. 113. 10–16. 2 indexed citations
7.
Schreiner, Sabrina, Mandy Glaß, Peter Groitl, et al.. (2013). Control of human adenovirus type 5 gene expression by cellular Daxx/ATRX chromatin-associated complexes. Nucleic Acids Research. 41(6). 3532–3550. 77 indexed citations
8.
Schreiner, Sabrina, Sarah Kinkley, Andreas Mund, et al.. (2013). SPOC1-Mediated Antiviral Host Cell Response Is Antagonized Early in Human Adenovirus Type 5 Infection. PLoS Pathogens. 9(11). e1003775–e1003775. 49 indexed citations
9.
Schreiner, Sabrina, Ruben Martinez, Peter Groitl, et al.. (2012). Transcriptional Activation of the Adenoviral Genome Is Mediated by Capsid Protein VI. PLoS Pathogens. 8(2). e1002549–e1002549. 56 indexed citations
10.
Schmid, Katharina, Daniel Wicklein, Peter Groitl, et al.. (2012). Expression of the coxsackie adenovirus receptor in neuroendocrine lung cancers and its implications for oncolytic adenoviral infection. Cancer Gene Therapy. 20(1). 25–32. 22 indexed citations
11.
Wimmer, Peter, Paola Blanchette, Sabrina Schreiner, et al.. (2012). Cross-talk between phosphorylation and SUMOylation regulates transforming activities of an adenoviral oncoprotein. Oncogene. 32(13). 1626–1637. 36 indexed citations
12.
Bayer, Wibke, Matthias Tenbusch, Ghulam Nabi, et al.. (2011). Improved vaccine protection against retrovirus infection after co-administration of adenoviral vectors encoding viral antigens and type I interferon subtypes. Retrovirology. 8(1). 75–75. 20 indexed citations
13.
Schreiner, Sabrina, Peter Wimmer, Peter Groitl, et al.. (2011). Adenovirus Type 5 Early Region 1B 55K Oncoprotein-Dependent Degradation of Cellular Factor Daxx Is Required for Efficient Transformation of Primary Rodent Cells. Journal of Virology. 85(17). 8752–8765. 53 indexed citations
14.
Dayoub, Rania, Peter Groitl, Thomas Dobner, et al.. (2010). Foxa2 (HNF-3β) regulates expression of hepatotrophic factor ALR in liver cells. Biochemical and Biophysical Research Communications. 395(4). 465–470. 18 indexed citations
15.
Wimmer, Peter, Sabrina Schreiner, Roger D. Everett, et al.. (2010). SUMO modification of E1B-55K oncoprotein regulates isoform-specific binding to the tumour suppressor protein PML. Oncogene. 29(40). 5511–5522. 46 indexed citations
16.
Ugocsai, Péter, György Paragh, Gerhard Liebisch, et al.. (2009). HIF-1beta determines ABCA1 expression under hypoxia in human macrophages. The International Journal of Biochemistry & Cell Biology. 42(2). 241–252. 26 indexed citations
17.
Blanchette, Paola, Peter Groitl, Frédéric Dallaire, et al.. (2008). Control of mRNA Export by Adenovirus E4orf6 and E1B55K Proteins during Productive Infection Requires E4orf6 Ubiquitin Ligase Activity. Journal of Virology. 82(6). 2642–2651. 62 indexed citations
18.
Schneider‐Brachert, Wulf, Vladimir Tchikov, Marten Jakob, et al.. (2006). Inhibition of TNF receptor 1 internalization by adenovirus 14.7K as a novel immune escape mechanism. Journal of Clinical Investigation. 116(11). 2901–2913. 83 indexed citations
19.
Ried, Thomas, Christoph Lengauer, Thomas Cremer, et al.. (1992). Specific metaphase and interphase detection of the breakpoint region in 8q24 of burkitt lymphoma cells by triple‐color fluorescence in situ hybridization. Genes Chromosomes and Cancer. 4(1). 69–74. 85 indexed citations
20.
Shtivelman, Emma, Berthold Henglein, Peter Groitl, Martin Lipp, & J. Michael Bishop. (1989). Identification of a human transcription unit affected by the variant chromosomal translocations 2;8 and 8;22 of Burkitt lymphoma.. Proceedings of the National Academy of Sciences. 86(9). 3257–3260. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven J. Werden Breakdown of academic impact, for papers by Frédérique Quignon Breakdown of academic impact, for papers by Andrew M. Lewis Breakdown of academic impact, for papers by Denise R. Shaw Breakdown of academic impact, for papers by Polly R. Etkind Breakdown of academic impact, for papers by Chiara Bovolenta Breakdown of academic impact, for papers by Marilyn R. Lander Breakdown of academic impact, for papers by Bhavin S. Parekh Breakdown of academic impact, for papers by Lex M. Cowsert Breakdown of academic impact, for papers by M Kuppuswamy
Rankless by CCL
2026